Associations between cytochrome P450 2 E1 genetic polymorphisms with the risk to develop acute lymphoblastic leukemia and serum concentrations of methotrexate

Shu-mei WANG,Lu-lu SUN,Wei-xin ZENG,Guo-liang ZHANG

DOI: https://doi.org/10.13699/j.cnki.1001-6821.2014.09.007

2014-01-01

Abstract:Objective To investigate the relations between CYP 2E1*5B (G-1293C) and CYP2E1*6 ( T7632A) polymorphisms with the risk to develop acute lymphoblastic leukemia ( ALL) and serum concen-trations of methotrexate ( MTX ).Methods Peripheral blood samples were obtained from 283 healthy control subjects and 91 children with a-cute lymphoblastic leukemia to extract genome DNA.Polymerase chain reaction-Restriction fragment length polymorphism ( PCR-RFLP) was used to detect genotypes of CYP2E1*5B and CYP2E1*6 polymor-phisms.Fluorescence polarization immunoassay ( FPIA) was employed to determine the serum concentrations of MTX at the 24 h and 42 h.Re-sults The frequency of C (*5 B ) allele in ALL children ( 24.73%) was significantly higher than that in healthy subjects ( 17.31%) ( P<0.05 ).The odds ratio ( OR) of C allele was 1.57 , significantly increas-ing the risk to develop ALL ( P<0.05 ).There were similar frequencies of genotypes and alleles at CYP2E1*6 in healthy subjects and ALL chil-dren and the CYP2E1*6 polymorphisms were not associated with the risk to develop ALL.There were no significant differences in the dose -adjusted serum concentration ( C/D ratio ) of MTX at the 24 h and 42 h among respective genotype groups at CYP 2E1*5B and CYP2E1*6.Conclusion CYP2E1*5B significantly in-creases the risk to develop ALL and C allele is a susceptible allele for ALL.However , there are no significant associa-tions between CYP2E1*6 polymorphisms and the risk to develop ALL.CYP2E1*5B and CYP2E1*6 polymorphisms are not associated with serum concentrations of MTX in ALL children.